Evoke Pharma Inc Investor Relations Material
Latest events
Q4 2024
Evoke Pharma Inc
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Evoke Pharma Inc
Access all reports
Evoke Pharma Inc. is a specialty pharmaceutical company focused on the development and commercialization of treatments for gastrointestinal (GI) disorders. The company’s primary focus is on addressing unmet medical needs related to conditions that affect GI motility. Evoke Pharma's products are designed to offer novel delivery methods to improve patient outcomes, particularly for those with chronic and debilitating GI issues. The company's approach involves enhancing therapeutic efficacy and patient convenience through innovative formulations. The company is headquartered in Solana Beach, California, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
EVOK
Country
🇺🇸 United States